Merck Sharpe & Dohme sues Sandoz to block Januvia generic
Healthcare 2021-02-15 9:43 pm By Spencer Fowler Steen | Melbourne
Please login to bookmark Close

US pharmaceutical giant Merck Sharp & Dohme has taken Sandoz to court for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Janumet and Januvia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au